Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,114	305	902	1,043	1,227	-
Market Cap Growth	-	-66.19%	-13.55%	-15.02%	-	-
Enterprise Value	1,112	238	693	732	946	-101
PE Ratio	-1.16	-1.16	-2.89	-5.05	-9.05	-
PS Ratio	19.77	5.11	244.64	-	-	-
PB Ratio	13.29	3.44	4.30	3.50	4.54	-
P/FCF Ratio	-1.23	-1.23	-3.49	-5.94	-10.83	-
P/OCF Ratio	-1.23	-1.23	-3.50	-5.97	-10.86	-
EV/Sales Ratio	18.65	3.99	188.13	-	-	-
EV/EBITDA Ratio	-1.05	-1.05	-2.35	-3.56	-7.00	2.42
EV/EBIT Ratio	-1.04	-1.04	-2.34	-3.55	-6.98	2.40
EV/FCF Ratio	-0.96	-0.96	-2.69	-4.17	-8.35	2.34
Debt / Equity Ratio	2.32	2.32	0.97	0.26	0.02	0.00
Debt / EBITDA Ratio	-0.91	-0.91	-0.69	-0.38	-0.04	-0.01
Debt / FCF Ratio	-0.83	-0.83	-0.78	-0.44	-0.04	-0.01
Quick Ratio	6.40	6.40	11.09	11.66	12.65	19.34
Current Ratio	7.08	7.08	11.57	12.09	12.96	20.33
Asset Turnover	0.18	0.18	0.01	0	0	0
Interest Coverage	-7.72	-7.72	-18.90	-	-	-
Return on Equity (ROE)	-294.90%	-294.90%	-134.00%	-54.10%	-60.70%	94.40%
Return on Assets (ROA)	-78.60%	-78.60%	-76.80%	-48.60%	-55.20%	-53.10%
Return on Capital (ROIC)	-81.84%	-81.84%	-73.19%	-55.04%	-49.58%	66.64%
Earnings Yield	-22.24%	-85.99%	-34.54%	-19.78%	-11.05%	-
FCF Yield	-21.00%	-81.18%	-28.62%	-16.84%	-9.24%	-
Buyback Yield / Dilution	-25.94%	-25.94%	-11.39%	-38.51%	-1835.11%	-48.68%
Total Shareholder Return	-25.94%	-25.94%	-11.39%	-38.51%	-1835.11%	-48.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).